THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES

Header Logo

Connection

Anjan Pradhan to Melanoma

This is a "connection" page, showing publications Anjan Pradhan has written about Melanoma.
Connection Strength

1.348
  1. Dual Targeting of the PDZ1 and PDZ2 Domains of MDA-9/Syntenin Inhibits Melanoma Metastasis. Mol Cancer Ther. 2023 Oct 02; 22(10):1115-1127.
    View in: PubMed
    Score: 0.780
  2. MDA-9/Syntenin in the tumor and microenvironment defines prostate cancer bone metastasis. Proc Natl Acad Sci U S A. 2023 Nov 07; 120(45):e2307094120.
    View in: PubMed
    Score: 0.196
  3. Engineering T Cells to Express Tumoricidal MDA-7/IL24 Enhances Cancer Immunotherapy. Cancer Res. 2021 05 01; 81(9):2429-2441.
    View in: PubMed
    Score: 0.163
  4. Role of MDA-7/IL-24 a Multifunction Protein in Human Diseases. Adv Cancer Res. 2018; 138:143-182.
    View in: PubMed
    Score: 0.132
  5. Insights into the Mechanisms of Action of MDA-7/IL-24: A Ubiquitous Cancer-Suppressing Protein. Int J Mol Sci. 2021 Dec 22; 23(1).
    View in: PubMed
    Score: 0.043
  6. The MDA-9/Syntenin/IGF1R/STAT3 Axis Directs Prostate Cancer Invasion. Cancer Res. 2018 06 01; 78(11):2852-2863.
    View in: PubMed
    Score: 0.033
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES